Product Description
Overall, the South Korean dental implant and final abutment market was valued at nearly $435 million in 2023. This is expected to increase over the forecast period at a CAGR of 3.5% to reach $555 million.
The full report suite on the South Korean market for dental implants and final abutments includes dental implants, final abutments, treatment planning software and surgical guides.
MARKET REPORT DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- COVID-19 Impact Analysis
- Market Drivers & Limiters
- Market Forecasts Until 2030, and Historical Data to 2020
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
SOUTH KOREA DENTAL IMPLANT MARKET TRENDS
In South Korea, numerous local and budget-friendly brands operate with considerably lower investments in marketing and research and development compared to major international implant manufacturers. This cost advantage enables them to engage in competitive pricing for implants while sustaining profitability. Although dental implants from prominent global companies command premium prices in the South Korean market, their market share is constrained because only a limited number of dentists and patients are willing or financially able to bear the premium costs.
- In 2023, Osstem Implant dominated the South Korean dental implant and final abutment market. Specializing in discount implants, Osstem offers innovative products through its TS System®, SS System®, US System®, and MS System®. With a focus on R&D, Osstem aims to expand its consumer base and capitalize on NHIS coverage for industry consolidation. The company’s global sales network, AIC education programs, and robust marketing strategies are expected to further boost its market share.
- Dentium, the second-leading competitor, collaborates with clinicians and institutions to produce innovative implant systems. Established in 2000, Dentium’s product range includes SuperLine®, Implantium®, SimpleLine II®, SlimLine®, Overdenture System®, and NR Line®. The NR Line® addresses narrow posterior ridges, showcasing Dentium’s commitment to innovation. The company’s competitiveness is sustained through ongoing R&D efforts in collaboration with government agencies, universities, and hospitals.
- Neobiotech, the third-leading competitor, was established in 2000 and closely follows Dentium in the dental implant and final abutment segments. Offering CMI EB®, CMI IT®, CMI IS®, and CMI IS II and IIIActive® implant systems, Neobiotech competes in the discount implant segment. The extended NHIS coverage is anticipated to benefit Neobiotech, easing competitive pressures and enabling it to gain market share over the forecast period. Intense competition persists for the second-leading position in the South Korean dental implant market.
MARKET SEGMENTATION SUMMARY
- Dental Implants Market – The market analysis is further broken down into segments by:
- Type: Premium, Value, Discount;
- Material: Titanium, Ceramic/Zirconia;
- *Procedure Type: One-stage, two-stage, and Immediate Loading;
- *Shape: Parallel Wall, Tapered;
- *Connection Type: Internal Connection, External Connection, On-Piece;
- *Application: Single-Tooth Application, Multi-Tooth Bridge Partial Arch Securement, Multi-Tooth Bridge Full Arch Securement, Denture Securement.
- Final Abutment Market – The chapter contains the market analysis which is categorized by:
- *Type: Cement-Retained, Screw-Retained, and Denture Retaining.
- Fabrication: Stock, Custom Cast, and CAD/CAM;
- Material: Titanium, Ceramic/Zirconia, Gold;
- Instrument Kit Market
- Treatment Planning Software Market
- Surgical Guide Market
*Segment is analyzed at a unit level only.
Research Scope Summary
| Report Attribute | Details |
|---|---|
| Region | South Korea |
| Base Year | 2023 |
| Forecast | 2024-2030 |
| Historical Data | 2020-2022 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Product Portfolios, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
